Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation
- PMID: 12819334
- DOI: 10.1148/radiol.2282020695
Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation
Abstract
Purpose: To identify characteristic features of growth hormone (GH)-producing pituitary adenomas.
Materials and methods: A total of 174 pathologically proven pituitary adenomas were evaluated retrospectively on magnetic resonance (MR) images to determine the signal intensity (on T2-weighted images), maximum diameter, and amount of suprasellar and infrasellar extension. For microadenomas, sellar depth was also measured. GH-producing adenomas were classified at histologic evaluation as densely or sparsely granulated. Specimens from 38 adenomas were stained to assess the amounts of fibrous tissue, iron, and amyloid they contained. Results were correlated with the size and hormonal activity of adenomas by using the chi2, unpaired t, and Mann-Whitney U tests.
Results: Among 174 pituitary adenomas, 42 were GH-producing adenomas. Of these, 16 were densely granulated, and 24 were sparsely granulated (two histologic specimens were lost). Signal intensity was evaluated among 153 adenomas. On T2-weighted MR images, hypointensity was seen more commonly in adenomas that produced GH (16 of 40 cases [40%]; P <.001) than in those that did not; hypointensity was nearly exclusive to densely granulated GH-producing adenomas. The amounts of amyloid, fibrous tissue, and iron contained in adenomas demonstrated little relationship with signal intensity. Average suprasellar extension was significantly smaller in adenomas that produced GH (-0.8 mm) than in those that did not (5.3 mm) (P <.001). GH-producing adenomas tended to demonstrate infrasellar extension rather than suprasellar extension. Average sellar depth associated with GH-producing microadenomas (13.3 mm) was significantly greater than for non-GH-producing microadenomas (9.7 mm; P <.001).
Conclusion: Characteristic features regarding growth direction and T2 signal intensity can be identified for GH-producing adenomas.
Copyright RSNA, 2003.
Similar articles
-
Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas.Neurosurg Focus. 2010 Oct;29(4):E4. doi: 10.3171/2010.7.FOCUS10155. Neurosurg Focus. 2010. PMID: 20887129
-
Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.Clin Endocrinol (Oxf). 2003 Dec;59(6):768-72. doi: 10.1046/j.1365-2265.2003.01921.x. Clin Endocrinol (Oxf). 2003. PMID: 14974920
-
A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.Exp Clin Endocrinol. 1991;98(3):223-7. doi: 10.1055/s-0029-1211121. Exp Clin Endocrinol. 1991. PMID: 1778242
-
Pathophysiology of acromegaly.Endocr Rev. 1983 Summer;4(3):271-90. doi: 10.1210/edrv-4-3-271. Endocr Rev. 1983. PMID: 6354702 Review.
-
Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.Eur J Endocrinol. 2007 Feb;156(2):203-16. doi: 10.1530/eje.1.02326. Eur J Endocrinol. 2007. PMID: 17287410 Review.
Cited by
-
Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas.Pituitary. 2017 Jun;20(3):358-371. doi: 10.1007/s11102-017-0803-0. Pituitary. 2017. PMID: 28342098
-
Pituitary Adenomas in Children: : Specific Imaging Features According to Hormonal Secretion.Clin Neuroradiol. 2025 Feb 7. doi: 10.1007/s00062-025-01499-3. Online ahead of print. Clin Neuroradiol. 2025. PMID: 39918630
-
The therapeutic response of somatotropinomas according to the T2-weighted signal intensity on the MRI.Med Pharm Rep. 2021 Oct;94(4):425-433. doi: 10.15386/mpr-1299. Epub 2021 Oct 30. Med Pharm Rep. 2021. PMID: 36105498 Free PMC article.
-
The utility of dynamic MRI in differentiating the hormone-producing ability of pituitary adenomas.Jpn J Radiol. 2021 Aug;39(8):741-748. doi: 10.1007/s11604-021-01121-9. Epub 2021 Apr 21. Jpn J Radiol. 2021. PMID: 33881731 Free PMC article.
-
Evaluation of diffusivity in pituitary adenoma: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation.Br J Radiol. 2016 Jul;89(1063):20150755. doi: 10.1259/bjr.20150755. Epub 2016 May 17. Br J Radiol. 2016. PMID: 27187598 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical